Actively Recruiting
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Led by NGM Biopharmaceuticals, Inc · Updated on 2026-04-01
136
Participants Needed
28
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
CONDITIONS
Official Title
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented active diagnosis of colorectal cancer.
- Cachexia defined by Fearon criteria of weight loss.
- Signed informed consent.
You will not qualify if you...
- Current active reversible causes of decreased food intake.
- Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.
- Have cachexia caused by other reasons.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 28 locations
1
NGM Clinical Study Site
Los Angeles, California, United States, 90033
Actively Recruiting
2
NGM Clinical Study Site
Los Angeles, California, United States, 90095
Actively Recruiting
3
NGM Clinical Study Site
Santa Rosa, California, United States, 95403
Actively Recruiting
4
NGM Clinical Study Site
Margate, Florida, United States, 33063
Actively Recruiting
5
NGM Clinical Study Site
Baltimore, Maryland, United States, 21201
Actively Recruiting
6
NGM Clinical Study Site
New York, New York, United States, 10065
Actively Recruiting
7
NGM Clinical Study Site
Toledo, Ohio, United States, 43608
Actively Recruiting
8
NGM Clinical Study Site
Youngstown, Ohio, United States, 44504
Actively Recruiting
9
NGM Clinical Study Site
Dallas, Texas, United States, 75390
Actively Recruiting
10
NGM Clinical Study Site
Kingwood, Texas, United States, 77339
Withdrawn
11
NGM Clinical Study Site
Laredo, Texas, United States, 78041
Actively Recruiting
12
NGM Clinical Study Site
Richmond, Virginia, United States, 23114
Actively Recruiting
13
NGM Clinical Study Site
Appleton, Wisconsin, United States, 54915
Actively Recruiting
14
NGM Clinical Study Site
Tbilisi, Georgia, 159
Actively Recruiting
15
NGM Clinical Study Site
Tbilisi, Georgia, 159
Actively Recruiting
16
NGM Clinical Study Site
Tbilisi, Georgia, 159
Actively Recruiting
17
NGM Clinical Study Site
Tbilisi, Georgia, 159
Actively Recruiting
18
NGM Clinical Study Site
Tbilisi, Georgia, 186
Actively Recruiting
19
NGM Clinical Study Site
Goyang, South Korea, 10326
Actively Recruiting
20
NGM Clinical Study Site
Goyang, South Korea, 1048
Actively Recruiting
21
NGM Clinical Study Site
Incheon, South Korea, 21565
Actively Recruiting
22
NGM Clinical Study Site
Seoul, South Korea, 2841
Actively Recruiting
23
NGM Clinical Study Site
Seoul, South Korea, 3080
Actively Recruiting
24
NGM Clinical Study Site
Seoul, South Korea, 6351
Actively Recruiting
25
NGM Clinical Study Site
Suwon, South Korea, 16247
Actively Recruiting
26
NGM Clinical Study Site
Taichung, Taiwan, 407216
Actively Recruiting
27
NGM Clinical Study Site
Taipei, Taiwan, 100225
Actively Recruiting
28
NGM Clinical Study Site
Taoyuan, Taiwan, 333423
Actively Recruiting
Research Team
N
NGM Study Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here